The endocannabinoid system (ECS) plays an important role in cardiometabolic risk and is also responsible for modulating energy balance, feeding behavior, hepatic lipogenesis, and glucose homeostasis. Evidence suggests an overactive ECS may lead to obesity and dyslipidemia. In this volume, an internationally renowned author team provides a unique and thorough analysis and distillation of ECS and its relationship to abdominal obesity, diabetes, and cardiovascular disease. Topics discussed include sleep apnea, The endocrine function of adipose tissue, visceral adiposity, hypertension, and the EC system's relation to the immune system, the liver, and the GI tract.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.